company background image
8095 logo

Astena Holdings TSE:8095 Stock Report

Last Price

JP¥508.00

Market Cap

JP¥20.0b

7D

6.3%

1Y

13.9%

Updated

20 Jun, 2024

Data

Company Financials

Astena Holdings Co., Ltd.

TSE:8095 Stock Report

Market Cap: JP¥20.0b

Astena Holdings Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Astena Holdings
Historical stock prices
Current Share PriceJP¥508.00
52 Week HighJP¥548.00
52 Week LowJP¥424.00
Beta0.094
11 Month Change3.04%
3 Month Change6.28%
1 Year Change13.90%
33 Year Change-20.63%
5 Year Change3.04%
Change since IPO-0.20%

Recent News & Updates

Recent updates

Astena Holdings (TSE:8095) Has Affirmed Its Dividend Of ¥9.00

Mar 04
Astena Holdings (TSE:8095) Has Affirmed Its Dividend Of ¥9.00

Shareholder Returns

8095JP PharmaceuticalsJP Market
7D6.3%-2.1%-0.8%
1Y13.9%-1.6%16.3%

Return vs Industry: 8095 exceeded the JP Pharmaceuticals industry which returned -1.6% over the past year.

Return vs Market: 8095 underperformed the JP Market which returned 16.3% over the past year.

Price Volatility

Is 8095's price volatile compared to industry and market?
8095 volatility
8095 Average Weekly Movement2.3%
Pharmaceuticals Industry Average Movement3.8%
Market Average Movement4.0%
10% most volatile stocks in JP Market7.4%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 8095 has not had significant price volatility in the past 3 months.

Volatility Over Time: 8095's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19141,404Satoshi Setoguchiwww.astena-hd.com

Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company’s Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas. Its Medical division manufactures and sells semi-solid products, such as ointments, creams, and lotions, as well as solid products such as tablets and powders for the generic drug market; and manufactures a range of dosage forms, including injectable, solid, semi-solid, and liquid dosage forms on contract.

Astena Holdings Co., Ltd. Fundamentals Summary

How do Astena Holdings's earnings and revenue compare to its market cap?
8095 fundamental statistics
Market capJP¥20.00b
Earnings (TTM)JP¥1.62b
Revenue (TTM)JP¥52.63b

12.4x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8095 income statement (TTM)
RevenueJP¥52.63b
Cost of RevenueJP¥35.64b
Gross ProfitJP¥16.98b
Other ExpensesJP¥15.37b
EarningsJP¥1.62b

Last Reported Earnings

Feb 29, 2024

Next Earnings Date

Jul 12, 2024

Earnings per share (EPS)40.84
Gross Margin32.27%
Net Profit Margin3.07%
Debt/Equity Ratio54.3%

How did 8095 perform over the long term?

See historical performance and comparison

Dividends

3.5%

Current Dividend Yield

44%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.